Online citations, reference lists, and bibliographies.

Long-term Antithrombotic Treatment In Intracranial Hemorrhage Survivors With Atrial Fibrillation

Eleni Korompoki, F. Filippidis, P. Nielsen, A. Del Giudice, Gregory Y. H. Lip, J. Kuramatsu, H. Huttner, J. Fang, S. Schulman, J. Martí-Fàbregas, C. Gathier, A. Viswanathan, A. Biffi, D. Poli, C. Weimar, U. Malzahn, P. Heuschmann, R. Veltkamp
Published 2017 · Medicine
Cite This
Download PDF
Analyze on Scholarcy
Objective: To perform a systematic review and meta-analysis of studies reporting recurrent intracranial hemorrhage (ICH) and ischemic stroke (IS) in ICH survivors with atrial fibrillation (AF) during long-term follow-up. Methods: A comprehensive literature search including MEDLINE, EMBASE, Cochrane library, clinical trials registry was performed following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement. We considered studies capturing outcome events (ICH recurrence and IS) for ≥3 months and treatment exposure to vitamin K antagonists (VKAs), antiplatelet agents (APAs), or no antithrombotic medication (no-ATM). Corresponding authors provided aggregate data for IS and ICH recurrence rate between 6 weeks after the event and 1 year of follow-up for each treatment exposure. Meta-analyses of pooled rate ratios (RRs) were conducted with the inverse variance method. Results: Seventeen articles met inclusion criteria. Seven observational studies enrolling 2,452 patients were included in the meta-analysis. Pooled RR estimates for IS were lower for VKAs compared to APAs (RR = 0.45, 95% confidence interval [CI] 0.27–0.74, p = 0.002) and no-ATM (RR = 0.47, 95% CI 0.29–0.77, p = 0.002). Pooled RR estimates for ICH recurrence were not significantly increased across treatment groups (VKA vs APA: RR = 1.34, 95% CI 0.79–2.30, p = 0.28; VKA vs no-ATM: RR = 0.93, 95% CI 0.45–1.90, p = 0.84). Conclusions: In observational studies, anticoagulation with VKA is associated with a lower rate of IS than APA or no-ATM without increasing ICH recurrence significantly. A randomized controlled trial is needed to determine the net clinical benefit of anticoagulation in ICH survivors with AF.
This paper references
[Intracerebral hemorrhage in anticoagulated patients: what do we do afterwards?].
Angela Vidal-Jordana (2012)
2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association.
Aj. Camm (2012)
Systematic review of observational research studying the long-term use of antithrombotic medicines following intracerebral hemorrhage.
Robert W. V. Flynn (2010)
The dilemma of resuming anticoagulation after intracranial hemorrhage: little evidence facing big fears.
Carlos Molina (2011)
Abstract T MP103: Long-Term Outcomes of Elderly Patients with Intracerebral Hemorrhage and Atrial Fibrillation
Melissa Stamplecoski (2014)
A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey.
Ron Pisters (2010)
Net Clinical Benefit of Warfarin in Patients With Atrial Fibrillation: A Report From the Swedish Atrial Fibrillation Cohort Study
Leif Friberg (2012)
New oral anticoagulants and the risk of intracranial hemorrhage: traditional and Bayesian meta-analysis and mixed treatment comparison of randomized trials of new oral anticoagulants in atrial fibrillation.
Saurav Chatterjee (2013)
Antiplatelet use after intracerebral hemorrhage
Akila N. Viswanathan (2006)
Can Patients Be Anticoagulated After Intracerebral Hemorrhage?: A Decision Analysis
M. Eckman (2003)
T Steiner (2015)
Use of Antithrombotic Therapy and Long-Term Clinical Outcome Among Patients Surviving Intracerebral Hemorrhage
Tobias Pilgaard Ottosen (2016)
Hemorragias intracerebrales en pacientes anticoagulados, ¿qué hacemos después?
Angela Vidal-Jordana (2012)
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
J. Hemphill (2015)
Hemorrhagic and ischemic
KK Andersen (2014)
Variation in Restarting Antithrombotic Drugs at Hospital Discharge After Intracerebral Hemorrhage
Marta Pasquini (2014)
Hemorrhagic and Ischemic Strokes Compared: Stroke Severity, Mortality, and Risk Factors
Klaus K. Andersen (2009)
Long-Term Outcome after Anticoagulation-Associated Intracerebral Haemorrhage with or without Restarting Antithrombotic Therapy
Celine S. Gathier (2013)
Intracerebral haemorrhage in anticoagulated patients, What do we do afterwards?
Angela Vidal-Jordana (2012)
Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study
Jonas Bjerring Olesen (2011)
2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation--developed with the special contribution of the European Heart Rhythm Association.
Aj. Camm (2012)
Antithrombotic Therapy To Prevent Stroke in Patients with Atrial Fibrillation
Robert G. Hart (2000)
Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation
Robert G. Hart (2007)
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.
Alessandro Liberati (2009)
Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
Christian T. Ruff (2014)
Nationwide survey of neuro-specialists' opinions on anticoagulant therapy after intracerebral hemorrhage in patients with atrial fibrillation
Koichiro Maeda (2012)
Association Between Blood Pressure Control and Risk of Recurrent Intracerebral Hemorrhage.
A. Biffi (2015)
Prevalence of atrial fibrillation in intracerebral hemorrhage.
Solveig Horstmann (2014)
Meta-analysis in clinical trials.
Rebecca Dersimonian (1986)
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
L. Morgenstern (2010)
Optimal Timing of Anticoagulant Treatment After Intracerebral Hemorrhage in Patients With Atrial Fibrillation
Johanna Pennlert (2017)
compared : stroke severity , mortality , and risk factors
M Paciaroni (2009)
2012 Focused Update of the ESC Guidelines for the Management of Atrial Fibrillation
A. Camm (2013)
Use of Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation Who Have a History of Intracranial Hemorrhage
Tze-Fan Chao (2016)
Assessing Risk of Bias in Included Studies
Julian P. T. Higgins (2008)
Bleeding risk assessment and management in atrial fibrillation patients: a position document from the European Heart Rhythm Association, endorsed by the European Society of Cardiology Working Group on Thrombosis.
Gregory Y H Lip (2011)
Apixaban in patients with atrial fibrillation.
Donald R. Lynch (2011)
Should oral anticoagulants be restarted after warfarin-associated cerebral haemorrhage in patients with atrial fibrillation?
Maurizio Paciaroni (2014)
Should anticoagulation be resumed after intracerebral hemorrhage?
J. Goldstein (2010)
EHRA practical guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation: executive summary.
Hein Heidbuchel (2013)
European Stroke Organisation (ESO) Guidelines for the Management of Spontaneous Intracerebral Hemorrhage
Thorsten Steiner (2014)
Anticoagulant reversal, blood pressure levels, and anticoagulant resumption in patients with anticoagulation-related intracerebral hemorrhage.
J. Kuramatsu (2015)
Long-term prognosis after intracerebral haemorrhage: systematic review and meta-analysis
M. T. C. Poon (2013)
Left atrial appendage occlusion in atrial fibrillation after intracranial hemorrhage
Solveig Horstmann (2014)
Restarting Anticoagulant Treatment After Intracranial Hemorrhage in Patients With Atrial Fibrillation and the Impact on Recurrent Stroke, Mortality, and Bleeding: A Nationwide Cohort Study
Peter Brønnum Nielsen (2015)
Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial
Jonathan Mant (2007)
Optimal Timing of Resumption of Warfarin After Intracranial Hemorrhage
Ammar Majeed (2010)

This paper is referenced by
Management von intrazerebralen Blutungen unter oraler Antikoagulation
J. Sembill (2019)
Left atrial appendage occlusion in high-risk patients: doing it is better than nothing
Vincenzo Vizzi (2018)
Antiplatelet Therapy After Spontaneous Intracerebral Hemorrhage and Functional Outcomes.
Santosh B. Murthy (2019)
Prevention of Recurrent Intracerebral Hemorrhage
Chirantan Banerjee (2018)
Oral anticoagulant re-initiation following intracerebral hemorrhage in non-valvular atrial fibrillation: Global survey of the practices of neurologists, neurosurgeons and thrombosis experts
Yan Xu (2018)
Effectiveness and Safety of Restarting Oral Anticoagulation in Patients with Atrial Fibrillation after an Intracranial Hemorrhage: Analysis of Medicare Part D Claims Data from 2010–2016
Terri V. Newman (2019)
Oral Anticoagulation in Asian Patients With Atrial Fibrillation and a History of Intracranial Hemorrhage
So-Ryoung Lee (2019)
DiDang Tang Inhibits Endoplasmic Reticulum Stress-Mediated Apoptosis Induced by Oxygen Glucose Deprivation and Intracerebral Hemorrhage Through Blockade of the GRP78-IRE1/PERK Pathways
Qingxia Huang (2018)
Management of therapeutic anticoagulation in patients with intracerebral haemorrhage and mechanical heart valves
J. Kuramatsu (2018)
Verschluss des linken Vorhofohrs bei nichtvalvulärem Vorhofflimmern
Karl Georg Haeusler (2019)
An Update on the Reversal of Non-Vitamin K Antagonist Oral Anticoagulants
Mark Terence P Mujer (2020)
Fourth European stroke science workshop
Stéphanie Debette (2018)
Considerations when restarting anticoagulants in patients with atrial fibrillation after bleeding
Monika Kozieł (2019)
Anticoagulants in Older Patients with Nonvalvular Atrial Fibrillation after Intracranial Hemorrhage
Sylvie Perreault (2019)
Schlaganfall und Hirnblutung unter Antikoagulation oder Thrombozytenfunktionshemmung – wann und wie erneut starten?
Joachim Roether (2020)
Corrigendum to: Global position paper on cardiovascular regenerative medicine
Intracerebral hemorrhage: an update on diagnosis and treatment
I. Hostettler (2019)
Cardioembolic Stroke Risk and Recovery After Anticoagulation-Related Intracerebral Hemorrhage
Meredith P Murphy (2018)
Resumption of oral anticoagulation after spontaneous intracerebral hemorrhage
J. Sembill (2019)
Anticoagulation resumption after intracranial hemorrhage in patients treated with VKA and DOACs.
Daniela Poli (2020)
Intrazerebrale Blutung: „hot topics“
Maximilian I. Sprügel (2019)
Resuming anticoagulants after anticoagulation-associated intracranial haemorrhage: systematic review and meta-analysis
Zien Zhou (2018)
Postoperative Anticoagulation After Neurologic Surgery.
Joel Z Passer (2018)
Beneficios y riesgos de los anticoagulantes orales en la fibrilación auricular
Vanessa Roldána (2019)
Incidence and prognostic factors for recurrence of intracerebral hemorrhage in patients with and without atrial fibrillation: A cohort study.
Thure Filskov Overvad (2020)
The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: executive summary.
Jan Steffel (2018)
Management of oral anticoagulation after intracerebral hemorrhage
J. Kuramatsu (2019)
Anticoagulants Resumption after Warfarin-Related Intracerebral Haemorrhage: The Multicenter Study on Cerebral Hemorrhage in Italy (MUCH-Italy).
Loris Poli (2018)
The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation.
Jan Steffel (2018)
Antithrombotic treatment for secondary prevention of stroke and other thromboembolic events in patients with stroke or transient ischemic attack and non-valvular atrial fibrillation: A European Stroke Organisation guideline
C.J.M. Klijn (2019)
Non–Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Atrial Fibrillation Patients With Intracerebral Hemorrhage
Peter Brønnum Nielsen (2019)
Cortical superficial siderosis progression in cerebral amyloid angiopathy
Thanakit Pongpitakmetha (2020)
See more
Semantic Scholar Logo Some data provided by SemanticScholar